Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Multiple growth factor receptors and corneal surface components refers to a collective group of molecular targets involved in the maintenance and repair of the ocular surface. This group includes various receptor tyrosine kinases such as the Epidermal Growth Factor Receptor (EGFR), Fibroblast Growth Factor Receptor (FGFR), and Vascular Endothelial Growth Factor Receptor (VEGFR), as well as structural components like mucins and integrins. These components play a critical role in corneal epithelial cell proliferation, migration, and adhesion, which are essential for wound healing and visual clarity. In disease states such as persistent epithelial defects or corneal neovascularization, these pathways are often dysregulated. Therapeutic interventions targeting these components aim to restore the physiological balance of growth factors and structural integrity to promote healing and prevent vision loss.
Modulation of multiple signaling pathways and structural integrity of the corneal epithelium and stroma.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple growth factor receptors and corneal surface components.